Vendor Intelligence Report: VIP Wellness Access

Published 2 Jul 2026. 14-page investigative report on who is behind VIP Wellness Access: corporate records, ownership, affiliate networks, and the vendor's lab-testing record. The first 3 pages are free to read on this page.

Researched and published by Finnrick Analytics. Reports draw on corporate records, affiliate-network analysis, and Finnrick's own laboratory testing record; vendors can challenge findings through the formal objections process at finnrick.com/vendor-support/objections.

Executive summary

Across 5 Finnrick lab tests, VIP Wellness Access records 2 passes and 2 failures, for an overall pass rate of 40%. The usable laboratory record is narrow: Tirzepatide is the only tested product, and the current file is mixed rather than stable. Passing samples prevent a blanket “all bad” read, but the failed entries are described as samples that did not contain Tirzepatide.

For a buyer comparing Tirzepatide sources, VIP Wellness Access is not a strong directional choice on the current record. The report flags identity failure as the main concern, then separates it from a second problem: even better-performing material raised dose-label accuracy questions. Ratings also become less forgiving under stricter dose and purity assumptions, and missing batch IDs make it impossible to tie safer-looking results to a vial lineage.

The OSINT trail does not supply the accountability signals that would normally soften a mixed test record. The listed domain was non-resolving during investigation, public WHOIS and Wayback checks produced no usable history, and no confirmed owner, legal entity, payment rail, or official social channel was identified. The dossier also separates a rejected Memphis spa-membership lead from an unconfirmed similarly named WordPress marketing page carrying an Austrian contact.

Inside the full report:

  • Finnrick vendor-page and Tirzepatide test-result exhibits, including methodology-divergence and trajectory visuals
  • Per-product pass/fail analysis for the one tested product, with the full laboratory appendix reserved for subscribers
  • DNS, WhoisFreaks, and Wayback verification results for vipwellnessaccess.com
  • Ownership trail covering the rejected Jasper Float Spa lead and the unconfirmed WordPress/Austrian-contact lead
  • Risk matrix for identity failure, traceability, brand-authenticity confusion, and dose-label accuracy
  • Investigation limitations and open leads on corporate registries, payment rails, sales channels, and supply-chain sourcing

Risk assessment

  • Tirzepatide identity-failure risk — high: The only graded product has 4 Finnrick Tirzepatide tests (2 pass / 2 fail); investigation test detail states the failed samples did not contain Tirzepatide.
  • Traceability and operator-accountability risk — high: vipwellnessaccess.com was non-resolving, no WHOIS/Wayback history or confirmed owner/legal entity was found, and tested vials lacked batch IDs.
  • Brand-authenticity / copycat-confusion risk — medium: Similar unrelated “VIP Wellness” leads surfaced while the vendor provided no resolving canonical site, official-channel list, or verifiable COA path.
  • Tirzepatide dose-label accuracy risk — medium: The Tirzepatide samples that passed were still documented in field test detail as above labeled quantity, creating dosing-precision concerns.